Skip to content
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Aethlon Medical Inc. AEMD

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$-7.2M
$-7.0M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2023 · Revenue 0.0 · Net income -12.2
1M2M-5M-10M
201020132016201920222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2022 · Operating -2072.0% · Net ·
-1000%-2000%-3000%
201020172025
ROE
FY2025 · ROE -142.9%
-200%-400%-600%
201020172025
Three returns, three denominators.

Each USD of equity lost 143 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -7.0
-5M-10M
201020172025

Total assetsUSD 6.3M
EquityUSD 4.9M
CashUSD 5.0M
Current ratio3.85×

Equity funds 77% of total assets.

The 16-year record

16 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
AEMD, 16-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B◌◌0.00.00.00.00.00.00.00.00.00.00.00.00.0◌
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.0◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−10.61−85.77−38.87−5.86−0.71−0.65−1.87−5.13−0.10−0.94−0.66−1.22−3.44−0.03−0.08−0.08
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————————
ROE %−142.9−245.9−117.2−75.1−78.8−83.7−107.7−144.8−166.8−652.8−449.4—————
Shares out B0.000.000.000.020.020.010.010.020.020.010.010.010.220.170.120.08

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 1 failure in 64 reconciliationsAUDITED

Reconciled in 15 of the 16 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency1 failure
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inNevada
Fiscal year endsMarch 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image